2-(3,4-bis(N-methylsulfamoyl)-1H-pyrrol-1-yl)-N-(3,5-dimethylphenyl)acetamide

ID: ALA4761604

PubChem CID: 20921881

Max Phase: Preclinical

Molecular Formula: C16H22N4O5S2

Molecular Weight: 414.51

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNS(=O)(=O)c1cn(CC(=O)Nc2cc(C)cc(C)c2)cc1S(=O)(=O)NC

Standard InChI:  InChI=1S/C16H22N4O5S2/c1-11-5-12(2)7-13(6-11)19-16(21)10-20-8-14(26(22,23)17-3)15(9-20)27(24,25)18-4/h5-9,17-18H,10H2,1-4H3,(H,19,21)

Standard InChI Key:  BYZLJWQEZWFJFE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 28  0  0  0  0  0  0  0  0999 V2000
   13.7767  -11.1807    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4866  -10.7762    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.7814  -10.3637    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7272   -9.8723    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9418   -9.0840    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.1518   -9.2923    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9694  -10.1159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7866  -10.1159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0410   -9.3392    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.3780   -8.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7193   -9.3392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8185   -9.0877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4251   -9.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2026   -9.3839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2540  -10.4345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.8091   -9.9316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6342  -10.7294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2399  -11.2768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0184  -11.0255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1878  -10.2217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5807   -9.6778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0685  -12.0758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9644   -9.9676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7717   -8.2877    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9944   -8.0355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8196  -11.5233    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3385  -12.1838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  5  4  2  0
  6  5  2  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11  7  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 18 22  1  0
 20 23  1  0
 11  5  1  0
  5 24  1  0
 24 25  1  0
  7  2  1  0
  2 26  1  0
 26 27  1  0
M  END

Associated Targets(non-human)

Fdps Farnesyl pyrophosphate synthase (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 414.51Molecular Weight (Monoisotopic): 414.1032AlogP: 0.56#Rotatable Bonds: 7
Polar Surface Area: 126.37Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.74CX Basic pKa: CX LogP: 0.88CX LogD: 0.86
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -1.49

References

1. Liu Q,Miao Y,Wang X,Lv G,Peng Y,Li K,Li M,Qiu L,Lin J.  (2020)  Structure-based virtual screening and biological evaluation of novel non-bisphosphonate farnesyl pyrophosphate synthase inhibitors.,  186  [PMID:31785819] [10.1016/j.ejmech.2019.111905]

Source